MedDataX Logo

Corticosteroids and Hemoglobin A1C Levels in Diabetic Patients With COPD Exacerbation

NCT ID: NCT01798420

Last Updated: 2013-02-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

42 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-04-30

Study Completion Date

2012-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Corticosteroid treatment in diabetic patients admitted for COPD exacerbation are expected to significantly increase hemoglobin A1C levels

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Changes in Mitochondrial Uncoupling Protein 2 (UCP2) Messenger RNA(mRNA) in Type 2 Diabetes (T2DM) Patients

NCT01781754

Diabetes
UNKNOWN

The Effect of Oxytocin on the Alpha Cell Response to Hypoglycaemia in Patients With Type 1 Diabetes

NCT06881459

Type 1 Diabetes
COMPLETED NA

Biomarkers in Exhaled Breath of Glucose Fluctuation in Type 1 Diabetes

NCT03435198

Volatile Organic Compounds Hypoglycemia Type 1 Diabetes Mellitus
COMPLETED

Very-Low-Density-Lipoprotein-Triglyceride(VLDL-TG) Metabolism During Acute Hyperglycemia

NCT01178957

Type 1 Diabetes
COMPLETED

Repeatability of Blood Glucose Responses to Resistance Exercise in Type 1 Diabetes

NCT05168488

Type 1 Diabetes
COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

HbA1C levels were evaluated in diabetic patients with COPD exacerbation on admission to the hospital and 3-months later. Demographic, clinical, laboratory variables and total steroid dose were documented. Age- and sex-matched group of diabetic patients with COPD who were admitted for other reasons, were asked to participate as a control group. Mann-Whitney and Chi square/Fischer's exact tests were used to compare between the parameters of the two groups. Wilcoxon signed rank test was used to compare between HbA1C levels at baseline and 3 months later. Multi-variate linear regression analysis was used to find predictors for increase in HbA1C levels in the patients' group.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Chronic Obstructive Pulmonary Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Corticosteroid

No interventions assigned to this group

non-corticosteroid group

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diabetic patients with COPD exacerbation

Exclusion Criteria

* Patients treated with steroids during the previous 3 months
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Nazareth Hospital, Israel

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

George Habib

Head, Rheumatology clinic, Nzareth hospital, Nzareth

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of medicine

Nzareth, Nazareth, Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Hb-A1C-2012

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Risk Factors for Atherogenesis in Type 1 Diabetes
NCT00035750 COMPLETED
Effect of Glucose on Ocular Blood Flow
NCT00350129 COMPLETED
The Effect of Hyperglycaemia on Local Energy Stores in the Working Muscle in Patients With Type 1 Diabetes Mellitus
NCT00325559 COMPLETED NA
Role of CBC as a Prognostic Marker for DKA Patients
NCT05666895 UNKNOWN
Non Invasive Breath Based Acetone-meter- Easy Check
NCT01530347 TERMINATED PHASE1
Registry of Diabetes Patients in a Large Health Maintenance Organization in Israel
NCT01779115 ENROLLING_BY_INVITATION
Study of 24 Hour Blood Pressure and the Association to Complications to Type 1 Diabetes
NCT01171248 COMPLETED
cArdiopulmonary exerCise Test Assessing Multiple biOmarkers and Hormones iN Type 1 diabetEs Under Different Circumstances
NCT05429359 UNKNOWN NA
Study of Cellular Impairments Involved in Diabetic Complications
NCT00985101 UNKNOWN
Counterregulatory Hormone Production in Adrenal Insufficiency and Diabetes Type I
NCT01452893 COMPLETED
Investigation of Chronotropic Index, Exercise Capacity in Type 1 Diabetes Mellitus
NCT04819815 COMPLETED
Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus
NCT00608101 WITHDRAWN NA
Diabetes Type 1 and Fitness.
NCT04968171 RECRUITING
The Metabolic Effects of Acute Hyperglycemia in Patients With Type 2 Diabetes
NCT00653510 COMPLETED NA
Myocellular Signalling in Skeletal Muscle
NCT03203317 COMPLETED NA
Optimized Glycemic Control in Heart Failure Patients With DM2:"Effect on Left Ventricular Function and Skeletal Muscle"
NCT01213784 COMPLETED PHASE2
Cardiovascular Effects of Exercise-related Hypoglycaemia in Patients With Type 1 Diabetes (Hypo Heart Exercise)
NCT04650646 COMPLETED NA
The Effect of Rapid and Slow Glucose Fall on the Subsequent Glucose Production in People With Type 1 Diabetes
NCT04098549 COMPLETED NA
The Effect of Triheptanoin in Adults With McArdle Disease (Glycogen Storage Disease Type V)
NCT02432768 COMPLETED PHASE2
The Relationship of Hemoglobin A1c and Diabetic Wound Healing
NCT01350102 TERMINATED PHASE4
Reproducibility of Glucose Fluctuations by Standardized Exercise for Patients With Type 1 Diabetes - a Method Study Based on Continuous Glucose Monitoring
NCT02942069 COMPLETED
A Pilot Study of Moderate Hyperbilirubinemia in Type 1 Diabetes Mellitus
NCT01421355 COMPLETED PHASE1
Involvement of Extrapancreatic Factors on Gastrointestinal-mediated Glucose Disposal
NCT02006459 COMPLETED
Novel Classification of Adult-onset Diabetes and Its Association With Common Microvascular Complications in Upper Egypt
NCT04847414 UNKNOWN
Pathogenesis of the Cardiometabolic Risk in Youth With Type 1 Diabetes
NCT04101045 TERMINATED NA